<div>
<h2>Key Points</h2><ul><li>Both SCHA and ISCB charge a low 0.04% expense ratio but differ sharply in assets under management and trading volume</li><li>SCHA delivered a higher 1-year total return, while ISCB has a slightly smaller historical drawdown and a marginally higher dividend yield</li><li>ISCB places more emphasis on Healthcare and Industrials, whereas SCHA leans into Technology exposure</li><li>10 stocks we like better than iShares Trust - iShares Morningstar Small-Cap ETF ›</li></ul><p>Schwab U.S. Small-Cap ETF (<strong>NYSEMKT:SCHA</strong>) and iShares Morningstar Small-Cap ETF (<strong>NYSEMKT:ISCB</strong>) both offer broad small-cap U.S. equity exposure at a 0.04% expense ratio, but SCHA is much larger and more liquid, while ISCB offers a slightly higher yield and a modest tilt toward Healthcare and Industrials.</p><p>For investors comparing SCHA and ISCB, both funds aim to capture the performance of U.S. small-cap stocks, yet they differ in scale, sector allocation, and recent returns. This analysis explores the key differences in cost, performance, risk, and portfolio makeup to help you decide which may fit your portfolio better.</p><h2 id="snapshot-cost-amp-size">Snapshot (cost &amp; size)</h2><section><table><tbody><tr><th>Metric</th><th>SCHA</th><th>ISCB</th></tr><tr><td>Issuer</td><td>Schwab</td><td>IShares</td></tr><tr><td>Expense ratio</td><td>0.04%</td><td>0.04%</td></tr><tr><td>1-yr return (as of 2026-04-22)</td><td>47.1%</td><td>38.4%</td></tr><tr><td>Dividend yield</td><td>1.1%</td><td>1.3%</td></tr><tr><td>Beta</td><td>1.10</td><td>1.08</td></tr><tr><td>AUM</td><td>$22.0 billion</td><td>$268.5 million</td></tr></tbody></table></section><p><em>Beta measures price volatility relative to the S&amp;P 500; beta is calculated from five-year monthly returns. The 1-yr return represents total return over the trailing 12 months.</em></p><p>Both ETFs are equally affordable on fees, but ISCB offers a marginally higher dividend yield. SCHA’s much larger size and higher trading volume may appeal to those prioritizing liquidity or institutional scale.</p><h2 id="performance-amp-risk-comparison">Performance &amp; risk comparison</h2><section><table><tbody><tr><th>Metric</th><th>SCHA</th><th>ISCB</th></tr><tr><td>Max drawdown (5 y)</td><td>-30.78%</td><td>-29.94%</td></tr><tr><td>Growth of $1,000 over 5 years</td><td>$1,346</td><td>$1,305</td></tr></tbody></table></section><h2 id="whatx27s-inside">What's inside</h2><p>ISCB tracks a broad mix of U.S. small-caps, with notable allocations to Industrials (18%), Financial Services (16%), and Healthcare (14%) as of its most recent report. The fund holds 1,554 stocks, with its largest positions in Lumentum Holdings Inc <span class="ticker">(NASDAQ:LITE)</span>, Revolution Medicines Inc <span class="ticker">(NASDAQ:RVMD)</span>, and Albemarle Corp <span class="ticker">(NYSE:ALB)</span>, each representing a small fraction of assets. With a fund age of nearly 22 years, ISCB has established a long track record.</p><p>By contrast, SCHA tilts more toward Technology (18%), alongside significant weights in Financial Services and Industrials (each 16%). Its top holdings include Sandisk Corp <span class="ticker">(NASDAQ:SNDK)</span>, Lumentum Holdings Inc <span class="ticker">(NASDAQ:LITE)</span>, and Revolution Medicines Inc <span class="ticker">(NASDAQ:RVMD)</span>. SCHA’s asset count is larger, with 1,729 holdings, suggesting slightly broader diversification within the small-cap space.</p><p>For more guidance on ETF investing, check out the full guide at this link.</p><h2 id="what-this-means-for-investors">What this means for investors</h2><p>When two funds track the same corner of the market at the same price, the decision usually comes down to conviction on the vehicle, not the strategy. Five years out, the gap between these two is $41 on a $1,000 investment — close enough that neither fund has proven a structural edge. What small-caps offer at a portfolio level is diversification away from mega-cap concentration, which has dominated large-cap indices for years, and a longer-run historical return premium that tends to materialize over decade-plus horizons, not quarters. The one meaningful difference is sector tilt: SCHA leans harder into Technology, ISCB into Healthcare — and in a significant drawdown, those behave differently. If you already have heavy Tech exposure elsewhere, ISCB's tilt offers a bit more balance. The more useful question either way is whether a 30% drop feels like a threat or an opportunity — investors who can buy into that kind of volatility rather than sell out of it will get considerably more out of whichever fund they choose.</p><h2>Should you buy stock in iShares Trust - iShares Morningstar Small-Cap ETF right now?</h2>
<p>Before you buy stock in iShares Trust - iShares Morningstar Small-Cap ETF, consider this:</p>
<p>The <em>Motley Fool Stock Advisor</em> analyst team just identified what they believe are the <strong>10 best stocks</strong> for investors to buy now… and iShares Trust - iShares Morningstar Small-Cap ETF wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.</p>
<p>Consider when <strong>Netflix</strong> made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, <strong>you’d have $500,572</strong>!* Or when <strong>Nvidia</strong> made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, <strong>you’d have $1,223,900</strong>!*</p>
<p>Now, it’s worth noting <em>Stock Advisor’s</em> total average return is 967<span>% — a market-crushing outperformance compared to 199% for the S&amp;P 500. <strong><span>Don't miss the latest top 10 list, available with <em>Stock Advisor</em>, and join an investing community built by individual investors for individual investors.</span></strong></span></p>
<p>See the 10 stocks »</p>
<p style="color: #767676; text-align: left"><em>*Stock Advisor returns as of April 24, 2026. </em></p><p><em>Seena Hassouna has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Lumentum. The Motley Fool has a disclosure policy.</em></p>
<p>The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.</p>
</div>

ISCB

SCHA

<p>SCHA and ISCB are both small-cap U.S. equity ETFs with a 0.04% expense ratio. SCHA has a larger asset base ($22 billion) and a higher 1-year return (47.1%) compared to ISCB's $268.5 million and 38.4% return. ISCB offers a slightly higher dividend yield (1.3%) and focuses more on Healthcare and Industrials, while SCHA leans towards Technology. Investors should consider their sector exposure and drawdown tolerance when choosing between the two funds, as both provide diversification in small-cap investments.</p>

SCHA vs. ISCB Comes Down to Sector Tilt and Your Drawdown Tolerance